Galmed Pharma (GLMD) Reports In-Line Q1 EPS

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.38), in-line with the analyst estimate of ($0.38).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
• Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP